APT Medical Overview
- Year Founded
-
2002
- Status
-
Public
- Employees
-
3,118
- Stock Symbol
-
688617
- Investments
-
7
- Share Price
-
$43.18
- (As of Thursday Closing)
APT Medical General Information
Description
APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.
Contact Information
Website
www.aptmed.comCorporate Office
- Room 601, Building B, Tongfang Information Port
- No.11 Langshan Road, Nanshan District
- Shenzhen, Guangdong
- China
Corporate Office
- Room 601, Building B, Tongfang Information Port
- No.11 Langshan Road, Nanshan District
- Shenzhen, Guangdong
- China
APT Medical Stock Performance
As of 19-Nov-2026, APT Medical’s stock price is $43.18. Its current market cap is $6.11B with 142M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $43.18 | $43.20 | $25.93 - $44.19 | $6.11B | 142M | 1.56M | $1.05 |
APT Medical Financials Summary
As of 30-Sep-2026, APT Medical has a trailing 12-month revenue of $446M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 5,035,496 | 4,716,990 | 4,844,104 | 3,503,918 |
| Revenue | 446,053 | 359,312 | 287,898 | 233,249 |
| EBITDA | 167,333 | 143,936 | 114,745 | 93,328 |
| Net Income | 147,337 | 114,115 | 93,813 | 75,468 |
| Total Assets | 599,828 | 521,940 | 408,309 | 362,975 |
| Total Debt | 1,789 | 2,773 | 1,546 | 12,676 |
APT Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
APT Medical Patents
APT Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260306242-A1 | Branch artery reconstruction assist device and s-c branch-first aortic reconstruction system | Pending | 01-Mar-2023 | ||
| EP-4674379-A1 | Branch artery reconstruction assisting device and s-c branch-first aorta reconstruction system | Pending | 01-Mar-2023 | ||
| WO-2024179549-A1 | Branch artery reconstruction assisting device and s-c branch-first aorta reconstruction system | Inactive | 01-Mar-2023 | ||
| JP-2026507226-A | Branch artery reconstruction auxiliary device and sc branch priority aortic reconstruction system | Pending | 01-Mar-2023 | ||
| EP-4403124-A1 | Ablation catheter | Pending | 13-Sep-2021 | A61B18/1492 |
APT Medical Signals
APT Medical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
APT Medical Investments (7)
APT Medical’s most recent deal was a Early Stage VC with Liliang Medical for . The deal was made on 22-Aug-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Liliang Medical | 22-Aug-2025 | Early Stage VC | Other Devices and Supplies | ||
| Shanghai Hong Tong Industries | 15-Jun-2025 | Corporate | Therapeutic Devices | ||
| Hunan EVD | 10-May-2023 | Later Stage VC | Surgical Devices | ||
| Ricoton | 10-Mar-2023 | Later Stage VC | Surgical Devices | ||
| Innosonics | 01-Apr-2022 | Corporate | Diagnostic Equipment |
APT Medical ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
31.16 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
APT Medical FAQs
-
When was APT Medical founded?
APT Medical was founded in 2002.
-
Where is APT Medical headquartered?
APT Medical is headquartered in Shenzhen, China.
-
What is the size of APT Medical?
APT Medical has 3,118 total employees.
-
What industry is APT Medical in?
APT Medical’s primary industry is Therapeutic Devices.
-
Is APT Medical a private or public company?
APT Medical is a Public company.
-
What is APT Medical’s stock symbol?
The ticker symbol for APT Medical is 688617.
-
What is the current stock price of APT Medical?
As of 19-Nov-2026 the stock price of APT Medical is $43.18.
-
What is the current market cap of APT Medical?
The current market capitalization of APT Medical is $6.11B.
-
What is APT Medical’s current revenue?
The trailing twelve month revenue for APT Medical is $446M.
-
What is APT Medical’s annual earnings per share (EPS)?
APT Medical’s EPS for 12 months was $1.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process